NasdaqGS - Nasdaq Real Time Price USD
Alnylam Pharmaceuticals, Inc. (ALNY)
304.01
+3.18
+(1.06%)
As of 3:36:46 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-45,111
-8,312
104,156
-541,274
-641,693
Investing Cash Flow
64,549
-116,840
-336,350
169,354
-273,300
Financing Cash Flow
309,332
294,159
172,131
425,753
1,247,118
End Cash Position
1,013,489
968,652
814,884
868,556
822,153
Income Tax Paid Supplemental Data
15,342
14,360
6,021
2,654
--
Interest Paid Supplemental Data
103,566
67,578
32,118
45,235
24,657
Capital Expenditure
-30,274
-34,277
-62,211
-72,059
-76,372
Issuance of Capital Stock
--
--
--
0
0
Issuance of Debt
--
0
0
1,016,111
500,000
Repayment of Debt
--
0
0
-762,107
0
Free Cash Flow
-75,385
-42,589
41,945
-613,333
-718,065
12/31/2021 - 6/1/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARWR Arrowhead Pharmaceuticals, Inc.
16.58
-1.37%
MDGL Madrigal Pharmaceuticals, Inc.
279.53
+0.47%
ARGX argenx SE
584.67
-0.22%
ASND Ascendis Pharma A/S
174.56
+0.86%
AXSM Axsome Therapeutics, Inc.
111.11
-0.71%
BBIO BridgeBio Pharma, Inc.
39.26
+1.66%
SRPT Sarepta Therapeutics, Inc.
39.70
-7.70%
IONS Ionis Pharmaceuticals, Inc.
36.91
+4.59%
MRUS Merus N.V.
55.24
-1.73%
BPMC Blueprint Medicines Corporation
127.79
-0.05%